Pathological mechanisms in Huntington's disease and other polyglutamine expansion diseases

A Lunkes1, Y Trottier, J L Mandel

  • 1Institut de Génétique et Biologie Moléculaire et Cellulaire, INSERM/CNRS/Université Louis Pasteur, Illkirch, France.

Essays in Biochemistry
|September 17, 1999
PubMed

Insights

Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene. This expansion leads to toxic protein aggregation and neuronal death, but the exact mechanism remains unclear.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder.
  • It is characterized by involuntary movements, cognitive decline, and mood disturbances.
  • Pathologically, HD involves significant neuronal loss in the striatum and cerebral cortex.

Purpose of the Study:

  • To investigate the genetic basis of Huntington's disease.
  • To understand the molecular mechanisms underlying polyglutamine expansion diseases.
  • To explore the formation and role of intracellular inclusions in neurodegeneration.

Main Methods:

  • Analysis of brain tissue from HD patients and mouse models.
  • Molecular and cellular studies focusing on protein aggregation.
  • Genetic analysis of CAG repeat expansions in the huntingtin gene.

Main Results:

  • The genetic defect in HD is an expanded CAG repeat in the huntingtin gene, encoding a polyglutamine stretch.
  • The size of the CAG expansion correlates inversely with the age of HD onset.
  • Abnormal intracellular inclusions, formed by aggregated mutant huntingtin protein, are observed in affected brains.

Conclusions:

  • Polyglutamine expansion is a novel mechanism of neurodegeneration, implicated in HD and seven other inherited disorders.
  • Mutant huntingtin protein gains a toxic function due to polyglutamine expansion.
  • The precise mechanisms by which polyglutamine expansion causes selective neuronal dysfunction and death are still under investigation.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...